SN4
SHORT NOTE
5M
★ High-yield
Describe the pathology of leprosy. Differentiate tuberculoid from lepromatous leprosy.
Definition
Leprosy (Hansen disease) is a chronic granulomatous infection caused by Mycobacterium leprae, an acid-fast bacillus with a special affinity for schwann cells of peripheral nerves and for the skin.
- Cannot be cultured in vitro; grown in the armadillo and the mouse footpad
- Prefers cooler parts of the body — skin, superficial nerves, nose, testis, eye — which determines the whole clinical picture
- Generation time about 12–14 days, the slowest of all bacteria; incubation is 2–5 years or more
- India accounts for more than half the world's new cases, so this remains an important subject despite elimination as a public health problem
The Spectrum of Disease
| Feature | Tuberculoid (TT) | Lepromatous (LL) |
|---|---|---|
| Cell-mediated immunity | Good | Poor or absent |
| Lepromin test | Positive | Negative |
| Bacillary load | Paucibacillary — few or no bacilli | Multibacillary — abundant bacilli in globi |
| Skin lesions | Few, large, well-defined, dry, anaesthetic, hypopigmented | Many, symmetrical, poorly defined, shiny; sensation preserved until late |
| Nerve involvement | Early, severe, asymmetrical; nerves thickened | Late, symmetrical, "glove and stocking" |
| Histology | Epithelioid granulomas with Langhans giant cells; nerve destroyed | Sheets of foamy macrophages (lepra or virchow cells) laden with bacilli; a clear GRENZ zone beneath the epidermis |
| T cell response | TH1, IFN-gamma | TH2, IL-4 and IL-10 |
| Infectivity | Low | High |
| Course | May heal spontaneously | Progressive; facies leonina, saddle nose, loss of eyebrows |
- Borderline forms (BT, BB, BL) lie between the two poles and are immunologically unstable, which is why they are the ones that develop reactions
CLINICAL PEARL
Leprosy is the classic demonstration that the host, not the organism, determines the disease. The same bacillus produces a paucibacillary, granulomatous, nerve-destroying illness in a person with good cell-mediated immunity, and a multibacillary, diffusely infiltrative one in a person without it. The tissue damage in tuberculoid leprosy is caused by the immune response itself.
Lepra Reactions
| Feature | Type 1 (reversal) | Type 2 (erythema nodosum leprosum) |
|---|---|---|
| Mechanism | Type IV (cell-mediated) hypersensitivity | Type III — immune complex deposition |
| Occurs in | Borderline forms | Lepromatous and borderline lepromatous |
| Features | Existing lesions become red, swollen and tender; acute neuritis with rapid nerve damage | Crops of tender subcutaneous nodules, fever, arthritis, iritis, orchitis |
| Treatment | Corticosteroids | Thalidomide or corticosteroids |
- Reactions are medical emergencies, because irreversible nerve damage and deformity occur within days if untreated
Diagnosis
- The cardinal signs — a hypopigmented or reddish patch with definite loss of sensation, a thickened peripheral nerve, or acid-fast bacilli in a slit-skin smear. Any one is sufficient
- Slit-skin smear stained by a modified Ziehl–Neelsen (Fite) method; graded by the bacteriological index
- Nerves commonly thickened — ulnar at the elbow, common peroneal at the fibular neck, great auricular, posterior tibial
- Skin biopsy for histology where the diagnosis is uncertain
Applied Aspects
- Multidrug therapy — rifampicin, dapsone and clofazimine; 6 months for paucibacillary and 12 months for multibacillary disease. It is provided free in India
- Deformity is caused by nerve damage, not by the bacillus — claw hand, foot drop, lagophthalmos and trophic ulcers all follow anaesthesia and paralysis
- Trophic ulceration of the anaesthetic foot is the commonest cause of disability; prevented entirely by protective footwear and daily self-examination
- Patients are non-infectious within days of starting rifampicin, which is the single most useful fact for countering stigma
- Stigma remains the greatest obstacle to early presentation in India, and late presentation is why deformity persists
All questions in Inflammation & Repair
- Q1Classify the chemical mediators of inflammation. Describe their sources and actions. ★
- Q2Define chronic inflammation. Describe its causes and the cells involved. Describe granulomatous inflammation with its causes. ★
- Q3Describe wound healing by first and second intention. Add a note on the factors influencing healing and its complications. ★
- Q4Describe the pathogenesis and morphology of tuberculosis. Differentiate primary from secondary tuberculosis. ★
- Q5Describe the outcomes and morphological patterns of acute inflammation. Describe the systemic effects of inflammation. ★
- SN1Define granuloma. Describe its components, types and causes. ★
- SN2Describe the types of giant cells with examples. ★
- SN3Describe the stages of fracture healing. Add a note on the factors affecting it and its complications. ★
- SN4Describe the pathology of leprosy. Differentiate tuberculoid from lepromatous leprosy. ★
- SN5Describe the complement system with its pathways and biological functions. ★
- SN6Differentiate keloid from hypertrophic scar. Add a note on the pathogenesis of keloid. ★
- SN7Describe granulation tissue with its components and significance.